GFR of 11 Indicates Stage 5 Chronic Kidney Disease (End-Stage Kidney Disease)
A glomerular filtration rate (GFR) of 11 mL/min/1.73 m² definitively classifies as Stage 5 chronic kidney disease (CKD), also known as kidney failure or end-stage kidney disease. 1
Classification of CKD Stages Based on GFR
CKD is staged according to GFR levels as follows:
- Stage 1: GFR ≥90 mL/min/1.73 m² with evidence of kidney damage
- Stage 2: GFR 60-89 mL/min/1.73 m² with evidence of kidney damage
- Stage 3a: GFR 45-59 mL/min/1.73 m²
- Stage 3b: GFR 30-44 mL/min/1.73 m²
- Stage 4: GFR 15-29 mL/min/1.73 m²
- Stage 5: GFR <15 mL/min/1.73 m² or requiring kidney replacement therapy 1
Clinical Implications of Stage 5 CKD
With a GFR of 11 mL/min/1.73 m², this patient has severely decreased kidney function that requires:
Immediate nephrology referral - Guidelines clearly state that patients with eGFR <30 mL/min/1.73 m² should be referred to a nephrologist 1
Preparation for renal replacement therapy - At this GFR level, the patient is approaching the need for dialysis or transplantation 2
Medication adjustments - Many medications require dose adjustment or discontinuation at this level of kidney function 1
Close monitoring - The patient requires frequent monitoring (recommended 3-4 times per year) as indicated by the "dark red" risk category in CKD progression grids 1
Mortality and Morbidity Considerations
Stage 5 CKD is associated with significantly increased risks:
- Cardiovascular mortality - CKD is an independent risk factor for cardiovascular events and death 1
- Progression to dialysis dependence - Without intervention, continued decline in kidney function is likely 3
- Uremic complications - Including metabolic acidosis, electrolyte abnormalities, and uremic symptoms 4
Management Priorities
For a patient with GFR of 11 mL/min/1.73 m²:
Nephrology consultation is mandatory for specialized care and dialysis planning 1
Dietary management - Protein intake should be aimed at 0.8 g/kg body weight per day for non-dialysis dependent patients 1
Medication optimization:
- Consider SGLT2 inhibitors if GFR ≥20 mL/min/1.73 m² 1
- Adjust or discontinue medications cleared by the kidneys
- Review for nephrotoxic medications that should be avoided
Vascular access planning if dialysis is anticipated
Transplant evaluation if the patient is a candidate
Common Pitfalls to Avoid
Delayed nephrology referral - This is associated with worse outcomes and should be avoided 5
Relying solely on GFR for dialysis initiation - The decision to start dialysis should not be based on GFR alone but should include assessment of uremic symptoms 2
Failure to discuss all treatment options - Including hemodialysis, peritoneal dialysis, transplantation, and conservative management 2
Inadequate medication review - Failure to adjust medications based on current renal function can lead to adverse effects 5
The patient with a GFR of 11 mL/min/1.73 m² has reached a critical stage of kidney disease requiring urgent specialist care and preparation for kidney replacement therapy or conservative management depending on individual circumstances.